I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Ramatroban for chemoprophylaxis and treatment of COVID-19: ..:
Chiang, Kate C
;
Rizk, John G
;
Nelson, Deanna J
...
Expert Opinion on Therapeutic Targets. , 2022
Link:
http://hdl.handle.net/10713/18182
RT Journal T1
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath
UL https://suche.suub.uni-bremen.de/peid=base-ftumarylandhshsl:oai:archive.hshsl.umaryland.edu:10713_18182&Exemplar=1&LAN=DE A1 Chiang, Kate C A1 Rizk, John G A1 Nelson, Deanna J A1 Krishnamurti, Lakshmanan A1 Subbian, Selvakumar A1 Imig, John D A1 Khan, Imran A1 Reddy, Srinivasa T A1 Gupta, Ajay PB Taylor and Francis Inc. YR 2022 K1 ARDS K1 COVID-19 K1 IL-13 K1 Ramatroban K1 SARS-CoV-2 K1 acute kidney injury K1 anti-platelet K1 antithrombotic K1 cyclooxygenase (COX) K1 fibrosis K1 immunomodulator K1 interferon K1 ischemia K1 long-haul COVID K1 lymphopenia K1 pharmacotherapy K1 platelets K1 prostaglandin D2 K1 thromboinflammation K1 thrombosis K1 thromboxane A2 JF Expert Opinion on Therapeutic Targets LK http://hdl.handle.net/10713/18182 DO http://hdl.handle.net/10713/18182 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)